ESR1 and breast neoplasm: In this study, we examined in ER+ MCF-7 breast tumor cells the effects of selection for anthracycline resistance and/or the altered expression of one or more AKRs on E2 metabolism, E2-dependent signaling pathways, expression of E2-dependent genes, cellular growth kinetics, and cellular survival in the presence of anthracyclines.